The usefulness of speckle tracking echocardiography for the prediction of cardiac involvement in patients with biopsy-proven sarcoidosis.
longitudinal strain
magnetic resonance
sarcoidosis
speckle tracking echocardiography
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
revised:
09
01
2024
received:
05
11
2023
accepted:
10
01
2024
medline:
25
3
2024
pubmed:
25
3
2024
entrez:
25
3
2024
Statut:
ppublish
Résumé
Cardiac sarcoidosis (CS) is commonly diagnosed based on clinical criteria and abnormalities in noninvasive imaging reported in patients with biopsy-proven extracardiac sarcoidosis. Electrocardiogram and two-dimensional echocardiography have a low sensitivity for CS detection. Cardiovascular magnetic resonance imaging (CMR) and positron emission tomography (PET) have limitations in terms of cost and availability. This study aimed to assess the usefulness of left ventricular longitudinal strain, measured using two-dimensional speckle tracking echocardiography (STE), for the prediction of late gadolinium enhancement (LGE) presence in CMR in patients with biopsy-proven sarcoidosis. A total of 119 patients with biopsy-proven extracardiac sarcoidosis were divided, according to the clinical criteria proposed by the 2014 Heart Rhythm Society expert consensus statement (HRS 2014), into two groups: 43 individuals with "probable cardiac sarcoidosis", CS(+) and 76 individuals without cardiac sarcoidosis, CS (-). Data from echocardiography, CMR, 12-lead ECG and 24 h Holter monitoring were analyzed. Left ventricular global longitudinal strain (LV-GLS) was slightly reduced in the entire sarcoidosis group (-18.61± 2.96), no difference between the CS (+) and CS (-) subgroups was found (-18.0% ± 3.2% and -18.9% ± 2.8%, respectively; p = .223). No cut-off value for LV-GLS was identified that could predict the presence of LGE. Segmental longitudinal strain impairment partially correlated with the presence of LGE on CMR. In our cohort of sarcoidosis patients, segmental longitudinal strain proved more helpful in the diagnostic process than LV-GLS. The ultimate role of STE in the diagnosis of CS remains to be established.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15777Subventions
Organisme : Medical University of Gdańsk
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Aggarwal NR, Snipelisky D, Young PM, et al. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2015;16:949‐958. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/
Ekström K, Lehtonen J, Nordenswanet HK, et al. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause‐of‐death registries. Eur Heart J. 2019;40:3121‐3128.
Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1304‐1323.
Terasaki F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol. 2017;3:42‐45.
Longcope WT, Freiman DG. A study of sarcoidosis, based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952;31:1‐132.
Joyce E, Ninaber MK, Katsanos S, et al. Subclinical left ventricular dysfunction determined by echocardiographic speckle‐tracking strain analysis is related to the outcome of sarcoidosis. Eur J Heart Fail. 2015;17:51‐62.
Felekos I, Aggeli C, Gialafos E, et al. Global longitudinal strain and long‐term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease. Echocardiography. 2018;35:804‐808.
Tigen K, Sunbul M, Karaahmet T, et al. Early detection of bi‐ven‐ tricular and atrial mechanical dysfunction using two‐dimensional speckle tracking echocardiography in patients with sarcoidosis. Lung. 2015;193:669‐675.
Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33:1344‐1352.
Orii M, Hirata K, Tanimoto T, et al. Myocardial damage detected by two‐dimensional speckle‐tracking echocardiography in patients with extracardiac sarcoidosis: comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2015;28:683‐690.
Stefano C, Bruno G, Arciniegas Calle MC, et al. Diagnostic and predictive values of speckle‐tracking echocardiography in cardiac sarcoidosis. BMC Cardiovasc Disord. 2020;20:21.
Chen J, Lei J, Scalzetti E, et al. Myocardial contractile patterns predict future cardiac events in sarcoidosis. Int J Cardiovasc Imaging. 2018;34:251‐262.
Değirmenci H, Demirelli S, Arısoy A, et al. Myocardial deformation and total atrial conduction time for the prediction of cardiac involvement in patients with pulmonary sarcoidosis. Clin Respir J. 2017;11:68‐77.
Lang RM, Badano LP, Mor‐Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28(1):1‐39.e14.
Dabir D, Meyer D, Kuetting D, et al. Diagnostic value of cardiac magnetic resonance strain analysis for detection of cardiac sarcoidosis. Fortschr Röntgenstr. 2018;190:712‐721.
Bayat F, Fahimi A, Tavana S, et al. Subclinical involvement of the heart and its associated factors in patients with sarcoidosis with normal systolic function using 2D speckle tracking. Echocardiography. 2020;37:41‐46.
Vita T, Okada DR, Veillet‐Chowdhury M, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11:e007030.
Komada T, Suzuki K, Ishiguchi H, et al. Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement. Nagoya J Med Sci. 2016;78:437‐446.